Crawford Nomination Heads For Committee Vote, But Obstacles Remain
This article was originally published in The Gray Sheet
Executive Summary
The Senate Health committee has scheduled a June 15 vote on the nomination of FDA Commissioner-designee Lester Crawford, following an HHS Inspector General investigation clearing him of allegations of misconduct
You may also be interested in...
Women’s Advocacy Groups Strive For FDA Transparency On Silicone Implants
A Freedom of Information Act request filed June 9 represents the National Organization for Women's latest effort to increase transparency in FDA's review of two silicone breast implant PMA applications
Women’s Advocacy Groups Strive For FDA Transparency On Silicone Implants
A Freedom of Information Act request filed June 9 represents the National Organization for Women's latest effort to increase transparency in FDA's review of two silicone breast implant PMA applications
Women’s Groups Urge Congress To Review Silicone Implant Panel Meeting
The Senate HELP Committee is reviewing a letter from six women's groups requesting a congressional oversight investigation into the recent FDA panel meeting on silicone breast implants